Thomas MacLellan on Rx Drug Abuse

Prescription Drug Monitoring Programs (PDMP) are effective tools for collecting and analyzing prescription data, but across the country they remain underused. Clinicians do not routinely check PDMP data to identify patients who are abusing or diverting prescription drugs so they can make appropriate decisions for treating individual patients. According to a report prepared for the Office of the National Coordinator for Health Information Technology in 2012, only 5 percent to 39 percent of providers use PDMP data, depending on the state.

Thomas MacLellan
,


CTD on 340B

The Coalition of Texans with Disabilities has been advocating on behalf of people with disabilities since 1978. We believe individuals with disabilities should be able to participate fully in all aspects of society. This includes employment, transportation, and healthcare. We have been working hard to ensure these individuals are able to continue to contribute to and be a part of society.

CTD
,


Kyle Keeney on 340B

Life science companies are creating a better Kentucky.  Not only are they creating jobs and building companies, but they do so while producing products that literally save Kentucky lives.  From Owensboro to Lexington, Universities to the private sector, we work together to make a difference in the commonwealth.  Whether it is a nurse in a rural clinic, a doctor in a major urban hospital, or a biotech researcher in a lab, they are all working to make people healthier. However, as is too often the case, good intentions are trumped by competition for the all-mighty dollar.

Kyle Keeney
,


Texas BioAlliance on 340B

Affordability and accessibility to lifesaving medicines is something we can all agree is important, especially among low income Americans and the indigent care population.

Texas BioAlliance
,


Michael Hazel
,


Robert Hugin at #PhRMA14

Mr. Hugin serves as Chairman and Chief Executive Officer of Celgene Corporation, a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for unmet medical needs in cancer and immune-inflammatory disease.  He joined Celgene in June 1999 and has been a Director of Celgene since December 2001.  Mr. Hugin also serves as a Director of The Medicines Company, Atlantic Health System, Inc. and of Family Promise, a national non-profit network assisting homeless families.

Pages

Subscribe to PhRMA RSS